Substrate-guided ablation of haemodynamically tolerated and untolerated ventricular tachycardia in patients with structural heart disease: effect of cardiomyopathy type and acute success on long-term outcome.

@article{Proietti2015SubstrateguidedAO,
  title={Substrate-guided ablation of haemodynamically tolerated and untolerated ventricular tachycardia in patients with structural heart disease: effect of cardiomyopathy type and acute success on long-term outcome.},
  author={Riccardo Proietti and Vidal Essebag and Jessica Beardsall and Philip Hache and Alfredo Pantano and Zaev A. Wulffhart and Rasna Juta and Bernice Tsang and Jacqueline Joza and Thais Nascimento and Vagner Pegoraro and Yaariv Khaykin and Atul Verma},
  journal={Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology},
  year={2015},
  volume={17 3},
  pages={461-7}
}
AIMS The purpose of this study was to evaluate the outcomes of purely substrate-guided ventricular tachycardia (VT) ablation in patients with non-ischaemic dilated cardiomyopathy (NIDCM) and ischaemic cardiomyopathy (ICM) and the impact of acute procedural success on long-term outcome. METHODS AND RESULTS One hundred and forty-two patients (65 ± 12 years old, 72% male) with ICM (n = 87) and with NIDCM (n = 55) underwent substrate-guided VT ablation. The ablation approach involved eliminating… CONTINUE READING